Freedom251 › AI Literature Review Software
RobotReviewer
What RobotReviewer is
RobotReviewer is an open-source tool for reviewing clinical trial reports. It annotates trial PDFs with PICO characteristics and likely risk-of-bias assessments based on the Cochrane Risk of Bias tool. Upload a PDF through the website to extract key data and see the results in a summary table. Its REST API can also process groups of trial reports to synthesize results across studies, making it usable for both individual papers and collections of reports.
RobotReviewer is free under the GNU GPL version 3.0. It supports web access and can be deployed locally as Docker services, with a web app and API server exposed on local ports. The self-hosted processing setup connects Grobid, RabbitMQ, Celery and SciBERT through bert-as-a-service. Docker instructions cover GPU use, and the worker can also run CPU-only. Manual setup calls for Python 3.6, TensorFlow 1.12.0 and the associated processing services. Installation is documented as tested on Ubuntu and Mac OS; Windows is supported with substantial installation difficulty. Maintainers ask users to cite the 2017 ACL paper and offer email support, including help integrating RobotReviewer into other software.
Who it suits
RobotReviewer suits researchers and review teams who need to extract PICO information and assess likely bias across clinical trial reports. It can also fit developers who want to process report groups through an API or incorporate the tool into other software.
What it does well
- Annotates PDFs with PICO characteristics and likely bias assessments.
- Website uploads produce extracted data and a summary table.
- API can synthesize results across groups of reports.
- Free to use under the GNU GPL version 3.0.
- Docker instructions cover GPU and CPU-only worker setups.
What to know first
- Manual setup requires several services and older software versions.
- Windows installation involves substantial difficulty.
- Self-hosted processing depends on Grobid, RabbitMQ, Celery and SciBERT.
Limits
The free plan is free of charge and open source under GPL-3.0. Manual setup requires Python 3.6, TensorFlow 1.12.0 and several processing services; Windows installation has substantial difficulty.
Plans
| Plan | Billed and limits | Price |
|---|---|---|
| Free | Free of charge · citation requested when used · attribution link required for integrations | Free |
As robotreviewer.net lists them, read 15 Oct 2026. The maker's own page has the final word.
Getting started
- Open the RobotReviewer website to upload a clinical trial PDF.
- For local deployment, follow the Docker instructions to run the web app and API server.
- Configure the document and worker services, including Grobid, RabbitMQ, Celery and SciBERT.
- Choose the documented GPU setup or run the worker CPU-only.
- For manual installation, use the documented Python 3.6 and TensorFlow 1.12.0 requirements.
RobotReviewer is a clinical-trial analysis tool that extracts PICO characteristics and likely bias assessments from PDFs. It is best for systematic reviewers and research teams that can manage a technical deployment or use its API. Its free, open-source model gives teams room to process reports without subscription costs, but setup takes substantial effort.
Overview
RobotReviewer applies the Cochrane Risk of Bias tool while identifying Population, Intervention, Comparator and Outcome details in trial papers. Reviewers can upload PDFs through the website, extract key data and view a summary table. For larger or repeatable workflows, the REST API can process groups of reports and synthesize results across trials. That makes it a more compelling fit for evidence teams than for someone who needs to check a single paper with minimal setup.
The GNU GPL version 3.0 license allows free use, and Docker services can run the web app and API locally. Local deployment offers control over where the application runs, but also means users take on installation and service management.
Key features
- PICO extraction and likely bias assessments: Automated annotations can help reviewers organize trial evidence and focus their assessment. They are useful inputs to a review, but the product presents likely bias assessments rather than a final judgment.
- PDF summaries: Upload a clinical-trial PDF through the website to extract key data and see it in a summary table. This provides a direct way to review a report without building an API workflow.
- Multi-report API processing: The REST API supports synthesis across groups of trial reports, which suits teams with recurring or programmatic workloads. The API endpoint code is in the project repository’s app.py.
- Flexible processing setup: The self-hosted stack uses Grobid for document processing, RabbitMQ and Celery for worker processing, and SciBERT through bert-as-a-service. Docker instructions cover GPU use, and the worker can also run CPU-only. This flexibility is valuable for technical teams, though the number of connected services adds deployment work.
Pricing
Free — free. The plan is free of charge and open source under GPL-3.0. It includes AI paper summaries, full-text analysis and systematic review support. There is no paid tier in this pricing model, so the trade-off is operational: users provide the setup and services needed to run it.
Platforms
RobotReviewer supports API, Linux, macOS, self-hosted, web and Windows use. Installation was tested on Ubuntu and Mac OS; Windows works with substantial installation difficulty. The documented manual setup calls for Python 3.6, TensorFlow 1.12.0, Grobid, RabbitMQ, Celery and SciBERT services. Docker offers a local deployment route, while the Windows caveat makes it a less practical choice for users who need a straightforward install on that system.
Who it's for
RobotReviewer fits systematic reviewers who want automated extraction from clinical-trial PDFs, teams that need to synthesize groups of reports through an API, and technically equipped users who value an open-source local deployment. It is a weaker fit for occasional users or teams without the capacity to install and maintain its processing services. Maintainers ask users to cite the 2017 ACL paper when using the project, and invite questions by email at [email protected], including requests for help incorporating RobotReviewer into other software.
Pros and cons
- Pros: Free use under GPL-3.0 avoids subscription fees; PDF uploads produce extracted data and a summary table; API processing can synthesize results across multiple trial reports; Docker supports local deployment and GPU or CPU-only worker setups.
- Cons: The manual installation requires several processing services and older software components; Windows installation is substantially difficult; teams must manage the deployment rather than relying on a simple standalone install.
Alternatives
AI Literature Review Software is a useful starting point for comparing tools across the broader category. Choose ASReview if you want a free, open-source option that runs on your own hardware or server. Rayyan may suit teams that prefer a freemium service with web and mobile apps and a Free plan capped at three active reviews and two reviewers. Choose Universal SLR Assistant for a free, open-source option with Linux, macOS, web and Windows support; cloud AI provider API fees may apply. Abstrackr is another free web option, with no seat limits or usage caps. Axelium may fit researchers who want a browser extension and web app with a free tier limited to one lifetime review and one seat. Elicit is an alternative for web-based research across more than 138 million papers, with unlimited search, summaries and chat on its Basic plan. LitFlow is worth considering for academic use, with a self-hosted and web offering operated by a university research project. Mapped Research may be a better fit for teams that need citation screening, PRISMA generation, open-access full-text retrieval and collaboration up to three collaborators on its Free plan.
Verdict
Choose RobotReviewer if your work centers on clinical-trial PDFs and you need PICO extraction, likely bias assessments or API processing across reports without subscription costs. Its strongest case is the combination of a focused analysis workflow and a free, locally deployable open-source project. Look elsewhere if your team cannot take on the multi-service installation, especially if you rely on Windows.
Verdict
Choose RobotReviewer if you need free clinical-trial PDF annotation, summary tables or API processing across groups of reports. Its open-source license and local Docker deployment offer flexibility, while setup involves several processing services and Windows installation is difficult.
Questions
How much does RobotReviewer cost?
The Free plan costs nothing. It is free of charge and open source under GNU GPL version 3.0.
What does RobotReviewer do with clinical trial PDFs?
It annotates PDFs with PICO characteristics and likely bias assessments using the Cochrane Risk of Bias tool. Website uploads can extract key data and show a summary table.
Can it process multiple reports?
Yes. Its REST API supports groups of clinical trial reports to synthesize results across trials.
Which platforms does RobotReviewer support?
Listed platforms are API, Linux, macOS, self-hosted, web and Windows. Installation is documented as tested on Ubuntu and Mac OS; Windows involves substantial installation difficulty.
Is RobotReviewer open source?
Yes. It is free to use under the GNU GPL version 3.0.
What is needed for self-hosting?
The documented setup uses Docker services or a manual setup with Python 3.6, TensorFlow 1.12.0, Grobid, RabbitMQ, Celery and SciBERT services.
Facts from RobotReviewer's own pages
- API
- A REST API exposes the underlying models for integration into systematic-review software. · pmc.ncbi.nlm.nih.gov, 15 Oct 2026
- API extensibility
- The API endpoint implementation is available in the repository's robotreviewer/app.py file. · github.com, 15 Oct 2026
- Batch synthesis
- The newer API works with groups of trial reports so results can be synthesized across multiple studies. · github.com, 15 Oct 2026
- Citation
- The maintainers ask users to cite the 2017 ACL paper when using RobotReviewer. · github.com, 7 Oct 2026
- Citation year
- The cited RobotReviewer evaluation was published in the Journal of the American Medical Informatics Association in 2015. · github.com, 15 Oct 2026
- Dependencies
- Installation requires Grobid, Java, RabbitMQ, Celery, spaCy, NLTK, TensorFlow, and SciBERT model files. · github.com, 15 Oct 2026
- Deployment
- The project can run locally as Docker services, with a web app and API server exposed on local ports. · github.com, 7 Oct 2026
- Docker deployment
- Docker Compose files are provided for building and running the web, API, and supporting services. · github.com, 15 Oct 2026
- Documentation depth
- The README includes Docker, manual installation, configuration, startup, API, testing, and troubleshooting instructions. · github.com, 15 Oct 2026
- Funding
- The project acknowledges NIH National Library of Medicine and UK Medical Research Council grant support. · github.com, 15 Oct 2026
- GPU option
- The project provides Docker instructions for GPU use and also documents running the worker CPU-only. · github.com, 7 Oct 2026
- GPU support
- A separate Docker Compose configuration supports NVIDIA GPU execution. · github.com, 15 Oct 2026
- Integration
- The research paper identifies Covidence and similar evidence-synthesis platforms as potential integration targets. · pmc.ncbi.nlm.nih.gov, 15 Oct 2026
- Integrations
- The self-hosted setup uses Grobid for document processing, RabbitMQ and Celery for worker processing, and SciBERT through bert-as-a-service. · github.com, 7 Oct 2026
- License
- RobotReviewer is open source under the GNU GPL version 3.0 license. · github.com, 15 Oct 2026
- Limit: human oversight
- Researchers in the real-time study still considered human input and discussion superior to semi-automated assessment. · pubmed.ncbi.nlm.nih.gov, 15 Oct 2026
- Limit: incomplete automation
- A 2026 scoping review describes RobotReviewer as time-saving but still requiring human supervision and reports uncertain reliability in some studies. · link.springer.com, 15 Oct 2026
- Limit: lower accuracy than humans
- The original evaluation reported overall risk-of-bias classification accuracy five to ten percentage points below published human systematic reviews. · pmc.ncbi.nlm.nih.gov, 15 Oct 2026
- Limit: scope
- The 2026 review reports that RobotReviewer is primarily evaluated on randomized trials and has limited evidence for other study designs. · link.springer.com, 15 Oct 2026
- Multiple reports
- The API supports groups of clinical trial reports to synthesize results across trials. · github.com, 7 Oct 2026
- Operating systems
- The documentation reports successful installation testing on Ubuntu and macOS, with Windows possible but difficult. · github.com, 15 Oct 2026
- PDF input
- The public service accepts clinical-trial documents in PDF form for automatic annotation. · github.com, 15 Oct 2026
- PDF summaries
- Users can upload PDFs through the website to extract key data and view a summary table. · github.com, 7 Oct 2026
- Performance range
- The 2026 scoping review reports published RobotReviewer accuracy estimates ranging from 71% to 78%. · link.springer.com, 15 Oct 2026
Where RobotReviewer stands on Freedom251
- AI Literature Review Software#2 of 38